EUDAMED UDI/Device Registration vs FDA GUDID: Key Differences for Exporters

EUDAMED UDI/Device Registration Registration of UDI and device information in EUDAMED for applicable medical devices. This article compares EUDAMED requirements with the US FDA’s GUDID system so exporters and logistics teams can meet both regimes when shipping devices between the United States and Europe.

Both EUDAMED and the FDA’s Global Unique Device Identification Database (GUDID) centralize device identification information, but they were designed for different regulatory systems. US exporters who supply EU customers often must satisfy both systems. This comparison highlights structural differences, data scope, actor responsibilities, and operational considerations that matter when preparing labels, documentation, and logistics flows.

Data Scope And Structure

EUDAMED and GUDID collect UDI-centric information, but the breadth and intended use differ:

• GUDID: Primarily stores device identifier records—device identifiers (DI) and associated device attributes focused on labeler-provided information for US market surveillance and supply chain use.
• EUDAMED: Stores Basic UDI-DI relationships, detailed device metadata, economic operator registrations, conformity assessment data and links to certificates and clinical investigations — supporting regulatory oversight across the device lifecycle.

Who Registers What

Actor responsibilities vary between systems, which affects who must prepare submissions:

• US Manufacturer In GUDID: The labeler (often the US manufacturer or its US-based labeler) submits GUDID records and is responsible for accuracy under FDA rules.
• EU Responsibilities In EUDAMED: The legal manufacturer is responsible for device records; if the manufacturer is outside the EU, an EU authorized representative must be appointed and registered as an actor in EUDAMED.

Regulatory Purpose And Use Cases

Understanding each system’s regulatory purpose helps shape business processes:

• GUDID Purpose: Supports US post-market surveillance, device identification, recalls and supply chain validation; many logistics partners query GUDID to validate identifiers.
• EUDAMED Purpose: Enables EU-level transparency, notified body oversight, vigilance coordination, and public access to regulatory metadata beyond simple identification.

Labeling And UDI Assignment Differences

Assigning and formatting UDIs must respect both regimes:

• Issuing Agencies: Both systems accept UDIs from accredited issuing agencies (e.g., GS1). Using a globally recognised issuing agency simplifies compliance across markets.
• Basic UDI-DI: EUDAMED requires a Basic UDI-DI concept that groups model-level data; GUDID focuses on the packaging level DI entered into the database for US distribution.
• Human-Readable Versus Machine-Readable: Both require machine-readable barcode/2D symbols on labels; verify symbol formats and data elements meet both FDA and MDR/IVDR rules to avoid re-labeling costs.

Operational Implications For Exporters

Practically, companies exporting devices between US and EU should consider:

• Single Source Data Model: Maintain a master product data file that maps GUDID fields to EUDAMED fields (e.g., basic UDI relationships, classification rules, certificate references).
• Actor Coordination: Ensure the EU authorized representative and importer are set up in EUDAMED; U.S. logistics teams should provide accurate labeler data for GUDID entries.
• Timing: Synchronize database submissions with CE marking milestones and US market entry to prevent gaps in market access.

Common Exporter Challenges

Exporters often face three challenges when managing both systems:

• Data Mismatch: Differences in required fields (e.g., clinical data references in EUDAMED) cause inconsistencies; reconcile early and use validation checks.
• Labeling Changes: Rework for EU label language, UDI placement or packaging hierarchy can be costly; plan label specifications for both jurisdictions at design stage.
• Responsibility Gaps: Confusion over who submits or maintains records—clarify contractual obligations with EU partners and authorized representatives.

Practical Example

A US manufacturer of infusion pumps uses GS1-issued UDIs and registers packaging-level DIs in FDA GUDID prior to US distribution. For EU launch, the company assigns a Basic UDI-DI to the pump model in addition to the packaging-level DIs, appoints an EU authorized representative, and ensures notified body certificate identifiers are linked in EUDAMED. The manufacturer’s master data file maps GUDID attributes to EUDAMED fields and prevents duplicate work during submissions.

In short, the EUDAMED UDI/Device Registration and FDA GUDID both serve device identification but differ in scope, actor responsibilities and regulatory context. Exporters should harmonize data models, appoint necessary EU actors, and align labeling and submission timing to meet both systems reliably.